Skip to main content
. 2015 Dec 28;31(1):125–133. doi: 10.3904/kjim.2016.31.1.125

Table 1.

Baseline characteristics of the patients

Characteristic CDI (n = 171) Non-CDI (n = 342) p value
Age, yr 71 (57.75–77) 71 (58–78) 0.907
Male sex 86 (50.3) 172 (50.3) 1.000
History
 Diabetes 56 (32.7) 94 (27.5) 0.219
 Hypertension 103 (60.2) 175 (51.2) 0.060
 ICU admission 64 (37.4) 58 (17.0) 0.000
 Use of any antibiotics 157 (91.8) 240 (70.2) 0.000
 GARD use 116 (67.8) 200 (58.5) 0.043
Advanced CKD (including ESRD) (eGFR < 60 mL/min/1.73 m2) 49 (28.7) 59 (17.3) 0.004
CKD stages < 0.001
 Non-advanced CKD (eGFR ≥ 60 mL/min/1.73 m2) 122 (71.3) 283 (82.7)
 Stage III CKD 17 (9.9) 41 (12.0)
 Stage IV–V CKD 10 (5.8) 8 (2.3)
 ESRD requiring dialysis 22 (12.9) 10 (2.9)
Reason for admission 0.148
 Surgical 57 (33.3) 137 (40.1)
 Nonsurgical 114 (66.7) 205 (59.9)
Admission type 0.005
 Elective 22 (12.9) 72 (21.1)
 Urgent 43 (25.1) 108 (31.6)
 Emergent 106 (62.0) 162 (47.4)
Length of hospital stay, day 43 (21–74) 10 (5–19) < 0.001
In-hospital mortality 14 (8.2) 9 (2.6) 0.006

Values are presented as median (confidence interval 25%–75%) or number of patients (%).

CDI, Clostridium difficile infection; ICU, intensive care unit; GARD, gastric acid-reducing drug; CKD, chronic kidney disease; ESRD, end-stage renal disease; eGFR, estimated glomerular filtration rate.